
Sun 18 April 2021
Warszawa (PL)
6/3°C
Fri
|
Sat
|
Sun
|
Mon
|
Tue
|
7 |
13 |
14 |
15 |
13 |
Sun 18 April 2021
Praha (CZ)
4/3°C
Fri
|
Sat
|
Sun
|
Mon
|
Tue
|
7 |
6 |
11 |
13 |
13 |
Sun 18 April 2021
Bratislava (SK)
8/4°C
Fri
|
Sat
|
Sun
|
Mon
|
Tue
|
9 |
11 |
12 |
11 |
13 |
Sun 18 April 2021
Budapest (HU)
6/5°C
Fri
|
Sat
|
Sun
|
Mon
|
Tue
|
9 |
12 |
10 |
11 |
14 |



February 8th, 2021
The Health Ministry will recommend the use of the drugs for COVID-19 based on monoclonal antibodies, namely kasirivimab and imdevimab from the Regeneron firm and bamlanivimab from the Eli Lilly firm, it said in a press release today. These drugs are suitable for people with a high risk of severe symptoms of the infection disease, for example patients after transplants. The target groups are yet to be defined.
CTK
Pageviews this month:
17,605